| __timestamp | BioMarin Pharmaceutical Inc. | Grifols, S.A. |
|---|---|---|
| Wednesday, January 1, 2014 | 302156000 | 660772000 |
| Thursday, January 1, 2015 | 402271000 | 736435000 |
| Friday, January 1, 2016 | 476593000 | 775266000 |
| Sunday, January 1, 2017 | 554336000 | 860348000 |
| Monday, January 1, 2018 | 604353000 | 814775000 |
| Tuesday, January 1, 2019 | 680924000 | 942821000 |
| Wednesday, January 1, 2020 | 737669000 | 985616000 |
| Friday, January 1, 2021 | 759375000 | 1061508000 |
| Saturday, January 1, 2022 | 854009000 | 1190423000 |
| Sunday, January 1, 2023 | 937300000 | 1254234000 |
| Monday, January 1, 2024 | 1009025000 |
Unleashing the power of data
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of leading companies is crucial. This analysis focuses on the Selling, General, and Administrative (SG&A) expenses of BioMarin Pharmaceutical Inc. and Grifols, S.A. from 2014 to 2023. Over this period, BioMarin's SG&A expenses surged by approximately 210%, reflecting a strategic investment in growth and market expansion. In contrast, Grifols experienced a 90% increase, indicating a more conservative approach.
By 2023, Grifols' SG&A expenses were about 34% higher than BioMarin's, highlighting its larger scale of operations. This trend underscores the differing business models and market strategies of these two pharmaceutical giants. As the industry evolves, monitoring such financial metrics provides valuable insights into corporate priorities and market positioning.
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Grifols, S.A.
Who Optimizes SG&A Costs Better? United Therapeutics Corporation or Grifols, S.A.
Incyte Corporation or Grifols, S.A.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and BioMarin Pharmaceutical Inc.
Comparing SG&A Expenses: Insmed Incorporated vs BioMarin Pharmaceutical Inc. Trends and Insights
Dr. Reddy's Laboratories Limited vs Grifols, S.A.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for BioMarin Pharmaceutical Inc. and Ascendis Pharma A/S
Who Optimizes SG&A Costs Better? BioMarin Pharmaceutical Inc. or Madrigal Pharmaceuticals, Inc.
Comparing SG&A Expenses: BioMarin Pharmaceutical Inc. vs Vericel Corporation Trends and Insights
BioMarin Pharmaceutical Inc. and Travere Therapeutics, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: BioMarin Pharmaceutical Inc. vs Xencor, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and PTC Therapeutics, Inc.